Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05014906Phase 4Completed
Phase 4, randomised, single-blind trial of Azelaic acid in rosacea (2 arms), sponsored by Dermatology Specialists Research. Primary endpoint: Reduction in total lesion count at 12 weeks. Started May 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05014906.